FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2746190369> ?p ?o ?g. }

• W2746190369 abstract "Chemotherapy response rates in patients with cholangiocarcinoma remain low, primarily due to the development of drug resistance. Epithelial-mesenchymal transition (EMT) of cancer cells is widely accepted to be important for metastasis and progression, but it has also been linked to the development of chemoresistance. Salinomycin (an antibiotic) has shown some potential as a chemotherapeutic agent as it selectively kills cancer stem cells, and has been hypothesized to block the EMT process. In this study, we investigated whether salinomycin could reverse the chemoresistance of cholangiocarcinoma cells to the chemotherapy drug doxorubicin. We found that combined salinomycin with doxorubicin treatment resulted in a significant decrease in cell viability compared with doxorubicin or salinomycin treatment alone in two cholangiocarcinoma cell lines (RBE and Huh-28). The dosages of both drugs that were required to produce a cytotoxic effect decreased, indicating that these two drugs have a synergistic effect. In terms of mechanism, salinomycin reversed doxorubicin-induced EMT of cholangiocarcinoma cells, as shown morphologically and through the detection of EMT markers. Moreover, we showed that salinomycin treatment downregulated the AMP-activated protein kinase family member 5 (ARK5) expression, which regulates the EMT process of cholangiocarcinoma. Our results indicated that salinomycin reversed the EMT process in cholangiocarcinoma cells by inhibiting ARK5 expression and enhanced the chemosensitivity of cholangiocarcinoma cells to doxorubicin. Therefore, a combined treatment of salinomycin with doxorubicin could be used to enhance doxorubicin sensitivity in patients with cholangiocarcinoma." @default.
• W2746190369 created "2017-08-31" @default.
• W2746190369 creator A5000723230 @default.
• W2746190369 creator A5028990016 @default.
• W2746190369 creator A5041610421 @default.
• W2746190369 creator A5051086315 @default.
• W2746190369 creator A5051351142 @default.
• W2746190369 creator A5057895109 @default.
• W2746190369 creator A5065637954 @default.
• W2746190369 creator A5076903478 @default.
• W2746190369 date "2017-01-01" @default.
• W2746190369 modified "2023-10-17" @default.
• W2746190369 title "Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5" @default.
• W2746190369 cites W1091583100 @default.
• W2746190369 cites W1575629882 @default.
• W2746190369 cites W1804602290 @default.
• W2746190369 cites W1863247901 @default.
• W2746190369 cites W1921369531 @default.
• W2746190369 cites W1964760839 @default.
• W2746190369 cites W1965568527 @default.
• W2746190369 cites W1970707684 @default.
• W2746190369 cites W1987981239 @default.
• W2746190369 cites W1995745530 @default.
• W2746190369 cites W1998728654 @default.
• W2746190369 cites W2005745857 @default.
• W2746190369 cites W2007848898 @default.
• W2746190369 cites W2016324311 @default.
• W2746190369 cites W2022873103 @default.
• W2746190369 cites W2031459394 @default.
• W2746190369 cites W2033732670 @default.
• W2746190369 cites W2044217732 @default.
• W2746190369 cites W2065949376 @default.
• W2746190369 cites W2075704079 @default.
• W2746190369 cites W2078236973 @default.
• W2746190369 cites W2094266198 @default.
• W2746190369 cites W2094883456 @default.
• W2746190369 cites W2104175716 @default.
• W2746190369 cites W2113112995 @default.
• W2746190369 cites W2115261608 @default.
• W2746190369 cites W2120656656 @default.
• W2746190369 cites W2124631712 @default.
• W2746190369 cites W2141078344 @default.
• W2746190369 cites W2152002064 @default.
• W2746190369 cites W2161817637 @default.
• W2746190369 cites W2166441970 @default.
• W2746190369 cites W2171348850 @default.
• W2746190369 cites W2336734951 @default.
• W2746190369 cites W2345163484 @default.
• W2746190369 cites W2524927879 @default.
• W2746190369 cites W2529157745 @default.
• W2746190369 doi "https://doi.org/10.1590/1414-431x20176147" @default.
• W2746190369 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5561806" @default.
• W2746190369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28832761" @default.
• W2746190369 hasPublicationYear "2017" @default.
• W2746190369 type Work @default.
• W2746190369 sameAs 2746190369 @default.
• W2746190369 citedByCount "16" @default.
• W2746190369 countsByYear W27461903692018 @default.
• W2746190369 countsByYear W27461903692019 @default.
• W2746190369 countsByYear W27461903692020 @default.
• W2746190369 countsByYear W27461903692021 @default.
• W2746190369 countsByYear W27461903692022 @default.
• W2746190369 crossrefType "journal-article" @default.
• W2746190369 hasAuthorship W2746190369A5000723230 @default.
• W2746190369 hasAuthorship W2746190369A5028990016 @default.
• W2746190369 hasAuthorship W2746190369A5041610421 @default.
• W2746190369 hasAuthorship W2746190369A5051086315 @default.
• W2746190369 hasAuthorship W2746190369A5051351142 @default.
• W2746190369 hasAuthorship W2746190369A5057895109 @default.
• W2746190369 hasAuthorship W2746190369A5065637954 @default.
• W2746190369 hasAuthorship W2746190369A5076903478 @default.
• W2746190369 hasBestOaLocation W27461903691 @default.
• W2746190369 hasConcept C121608353 @default.
• W2746190369 hasConcept C126322002 @default.
• W2746190369 hasConcept C2776694085 @default.
• W2746190369 hasConcept C2777877089 @default.
• W2746190369 hasConcept C2779013556 @default.
• W2746190369 hasConcept C2781303535 @default.
• W2746190369 hasConcept C501593827 @default.
• W2746190369 hasConcept C502942594 @default.
• W2746190369 hasConcept C55493867 @default.
• W2746190369 hasConcept C71924100 @default.
• W2746190369 hasConcept C76419328 @default.
• W2746190369 hasConcept C86803240 @default.
• W2746190369 hasConcept C98274493 @default.
• W2746190369 hasConceptScore W2746190369C121608353 @default.
• W2746190369 hasConceptScore W2746190369C126322002 @default.
• W2746190369 hasConceptScore W2746190369C2776694085 @default.
• W2746190369 hasConceptScore W2746190369C2777877089 @default.
• W2746190369 hasConceptScore W2746190369C2779013556 @default.
• W2746190369 hasConceptScore W2746190369C2781303535 @default.
• W2746190369 hasConceptScore W2746190369C501593827 @default.
• W2746190369 hasConceptScore W2746190369C502942594 @default.
• W2746190369 hasConceptScore W2746190369C55493867 @default.
• W2746190369 hasConceptScore W2746190369C71924100 @default.
• W2746190369 hasConceptScore W2746190369C76419328 @default.
• W2746190369 hasConceptScore W2746190369C86803240 @default.
• W2746190369 hasConceptScore W2746190369C98274493 @default.
• W2746190369 hasIssue "10" @default.
• W2746190369 hasLocation W27461903691 @default.

• next